Stemsynergy Therapeutic
Innovative Targeted Cancer Therapeutics
Miami, United States · Founded 2016 · $2.0M raised
- Headquarters
- Miami, Florida
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Website
- stemsynergy.com
- Total Funding
- $2.0M
- Last Round
- $2.0M GrantApr 2022
- Rounds
- 2
About
StemSynergy Therapeutics (SSTI) is a biotechnology company focused on discovering and developing novel therapeutics that target cancer stem cell pathways, including Wnt, Notch, Myc, and Sonic Hedgehog signaling. The company holds two awarded patents and one pending for breakthrough cancer stem cell modulation technologies, with six innovative therapeutic agents in its preclinical pipeline.
Summary
Stemsynergy Therapeutic is a Biotech company based in Miami, United States, founded in 2016. It has raised $2.0M in total across 2 rounds, most recently a $2.0M Grant round in Apr 2022. Investors include National Institutes of Health and National Cancer Institute.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...